Background: Human echinococcosis is a neglected infectious disease affecting more than 1 million people globally. Its diagnosis is expensive and difficult because of lack of adequate resources in low-resource locations, where most cases occur.
Human echinococcosis (HE) is among the most neglected parasitic diseases caused by the larval tapeworms of genus Echinococcus. The most frequent clinical forms of HE are cystic echinococcosis (CE) and alveolar echinococcosis (AE), caused by the zoonotic species E. granulosus and E. multilocularis, respectively. The larval growth of these parasites determines whether the malignant AE or benign CE is formed [1] . Human infection occurs through the ingestion of parasite eggs contaminating water, food, and soil, or through direct contact with animal hosts, such as dogs and sheep. Chronic infections in humans are characterized by an initial asymptomatic period that could last several years prior to the onset of clinical signs associated with pressure effect exerted either by cyst or tissue necrosis in the affected area (in the case of CE), or by the development of a tumor-like lesion, often in the liver (in the case of AE).
HE is a disease of major public health concern that is globally spread, particularly in developing regions with limited economic resources, whereas in some areas it has become an emerging or reemerging disease [2] [3] [4] [5] [6] . The CE form of the disease is globally distributed in every continent. The AE form, which is life threatening (90% of AE patients die if left untreated), is endemic in most regions of China and is reemerging many European countries [6, 7] . AE is considered to be one of the most pathogenic zoonosis in temperate and arctic regions of Europe [8] . In the endemic areas, CE infection ranges from less than 1 to 200 per 100 000 persons/year, and that of AE from 0.03 to 1.2 per 100 000 persons/year [9, 10] . The mortality rate of CE is low, but might increase considerably if medical treatment and care are inadequate [9] .
The diagnosis of HE is generally done through ultrasonography imaging, and is usually complemented, or validated, by different serological tests and computed tomography and/or magnetic resonance imaging scans [3, 11] . Both the diagnosis and treatment are expensive and complicated, in some cases the treatment requiring extensive surgery and/or prolonged drug therapy [4] .
Facing such challenges, fast and easy diagnosis of echinococcus infections at an early stage is highly desirable to enhance treatment success [12] . Diagnosis through exhaled breath analysis has been proposed in the last years as a convenient and safe complementary diagnostic method for several diseases, as breath sampling is noninvasive, secure, simple and easy to perform [13] [14] [15] [16] . Chemical analysis of exhaled breath composition provides specific breath patterns of volatile organic compounds (VOCs) that are strongly correlated with a disease state [13, 14] . Recently, exhaled breath analysis with chemical sensors based on functional nanomaterials has enabled important progress [14, 17, 18] , and promising results have been obtained for the diagnosis of different cancers [19] [20] [21] [22] [23] [24] , kidney injury [25] , chronic kidney disease [23, 26, 27] , diabetes mellitus [27, 28] , and Alzheimer and Parkinson diseases [23, 29] , among others [23] .
In the present study, we show for the first time a rapid, secure, user-friendly, noninvasive, and cost-effective diagnostic system for the discrimination and diagnosis of the 2 main echinococcus infections: CE and AE. The method is based on the detection and analysis of VOCs in exhaled breath with an array of chemoresistive gas sensors based on organic ligand-metal nanoparticle (MNP) nanoassemblies [30, 31] . Moreover, the possible origin of VOCs is discussed.
METHODS

Ethics Statement
The study protocol, consent forms, and procedures were reviewed and approved by the Institut Pasteur de Tunis Ethical Review Board (Tunisia) and the Independent Bioethical Commission for Science Research at the Medical University of Gdańsk (Poland). All patients and controls provided written informed consent for the collection of their breath samples and subsequent analysis. Only adult volunteers participated in the study. The personal data collected for the purpose of this study were anonymized by applying the aggregation and K-anonymity anonymization techniques.
Study Population
Thirty-two patients diagnosed with CE were recruited at 2 medical centers in Tunisia (Charles Nicolle Hospital, Tunis Government, and Abderrahman Mami Hospital, Ariana Government). After anamnestic, clinical, radiological, and ichnographical suspicion of CE, an enzyme-linked immunosorbent assay (ELISA) serological investigation using a commercial kit (Ridascreen® Echinococcus IgG) was performed for CE diagnosis. Some cases were further confirmed after surgery. Forty-three CE controls (here denominated CCE) were selected from healthy medical personnel working in these clinics who did not have contact with the etiological agent of CE. Control group volunteers were age and sex matched with the CE patients as much as possible.
Sixteen patients diagnosed with AE were recruited from adult patients without pulmonary disorders hospitalized at the Clinic of Tropical and Parasitic Diseases, Gdynia, Poland. Several tests were performed for AE diagnosis: serological tests (ELISA, western blot), analysis of DNA samples by polymerase chain reaction (PCR), real-time PCR, and microscopic detection of parasites. Eight AE controls (here denominated CAE) were selected from volunteered personnel of the Clinic of Tropical and Parasitic Diseases, Gdynia. Although they were age and sex matched with the AE patients as much as possible, age matching was not accurately achieved, because most of the personnel of the clinic were younger (below 40, with only 1 exception) as compared with AE patients (over 40, with only 1 exception).
Information regarding the volunteers included in each study, and statistical information regarding the study groups from each analysis performed, are provided in the Supplementary data.
Breath Samples Collection
The volunteers were asked to fast overnight before breath samples collection. Exhaled alveolar breath was collected employing a simple and easy-to-use BioVOC TM breath sampler (Markes International, UK). The volunteers exhaled normally through a disposable mouthpiece into the BioVOC until empting the lungs. The breath sampler, with an open end without return, ensured that only the last portion of the exhaled air, corresponding to the alveolar breath that has the lowest concentration of exogenous contaminants and is most likely to contain high concentration of the VOCs characteristic to the disease [32] , was retained inside the breath sampler. A plunger, replacing the mouthpiece, was steadily pushed during approximately 10 seconds throughout the whole volume of the BioVOC. This transferred the alveolar breath retained inside the breath sampler either into the sensors' test chamber or into 2-bed ORBO 420 Tenax TA sorption tubes (Sigma-Aldrich, Spain), which were stored for approximately a year at 4°C in a freezer for biomedical samples until analysis. To fill a sorbent tube, the entire process was repeated twice for each volunteer in order to ensure a higher concentration of the volatiles retained by the sorbent material.
Breath Samples Analysis
Seventy-six breath samples collected from patients diagnosed with CE and AE and the corresponding healthy controls groups (CCE and CAE) were analyzed employing a gas chromatograph (GC) coupled to a mass spectrometer (MS) with quadruple time of flight (GC/Q-TOF) equipment (Agilent G7200A). Ninety-six breath samples collected from patients diagnosed with CE and AE and the corresponding healthy controls groups (CCE and CAE) were measured with an array of 8 chemoresistive gas sensors based on ultrapure organically functionalized MNPs, using either a direct sensing method or an indirect sensing method. Detailed information on the analytical measurements, sensors' fabrications, and sensing measurements is provided in the Supplementary data. The list of ligand-nanoparticles nanoassemblies employed in this study and sensors' baseline characterization are presented in Table 1 .
Data Analysis and Pattern Recognition
The putative breath biomarkers were identified by applying a 2-tailed t test for normally distributed data. A standard cutoff value α = 0.05 was used for statistical significance between groups. The confounding factors assessed in this study were volunteers' gender (for all studies) and age (in the case of the CE study only, because as explained in section "Study Population" the AE and CAE groups could not be age matched). The 3 defined age groups were: young (18-29 years), middle-aged (30-49 years), and senior (>50 years). Smoking habit was not assessed as a confounding factor because of the low number of volunteers participating in the study who were smokers.
In the sensing measurements, 3 features were extracted from the response of each sensor to the breath samples during the first measurement cycle: F1, mean direct current (DC) acquired during 1.22 seconds (11 sampling points) at the middle of sensor exposure to the breath sample; F2, mean DC current acquired during the last 1.22 seconds (last 11 sampling points) of sensor exposure to the breath sample; F3, area under the response curve during the last 1.78 seconds (last 16 sampling points) of sensor exposure to the breath sample.
Discriminant factor analysis (DFA) was used for building classification models [33] . The input variables for DFA were the features extracted from the sensors' responses. The discrimination power of the model was estimated through leave-one-out cross-validation. All DFA classification models were tested for cross-influence of confounding factors (gender and age). Each DFA diagnostic model was further evaluated using the receiver operating characteristic (ROC) curve analysis of the most discriminating canonical variable (CV1) of the DFA model.
RESULTS
Chemical Analysis
Breath samples of 55 volunteers (23 patients with CE and 32 CCE controls) were measured with the GC-Q/TOF analyzer for the identification of CE biomarkers, and breath samples of 21 volunteers (13 patients with AE and 8 CAE controls) were measured for the identification of AE biomarkers. The chemical analyses revealed more than 400 compounds in each breath sample. Two VOCs were found in statistically different concentrations in the breath of CE and CCE groups, while concentrations of 7 VOCs were statistically different in the breath of AE and CAE groups. These compounds, presented in Table 2 , represent putative breath biomarkers for CE and AE. The abundance of these compounds in the breath samples of all volunteers from each study group is shown in Figure 1 .
Importantly, the concentration of both CE biomarkers increased compared to their corresponding controls, whereas the concentration of all AE biomarkers decreased as compared to their corresponding controls. It is remarkable that the putative biomarkers found for the 2 forms of the disease, CE and AE, are totally different. Thus, even though these diseases are from the same family of Echinococcus, the pathogenesis of CE and AE infections and the changes that they produce in body chemistry appear to be completely different [19, 23] .
A discussion on the possible origin of the breath biomarkers for each type of the echinococcosis disease is presented in sections "Cystic Echinococcosis" and "Alveolar Echinococcosis".
Cystic Echinococcosis
E. granulosus infection is always asymptomatic and persists without noticeable pathologic events for a long period of time while a hydatid cyst develops to avoid host immune responses. As a result, the parasite modulates host immune reaction to reduce the host response to pathogen invasion [34] . More specifically, antigen B from the hydatid cyst fluid guarantees parasite survival by suppressing human neutrophil chemotaxis, inhibiting lipid detoxification, and affecting the metabolism by fatty acid binding, as well as by increasing cytokine dysfunctions [35] . Therefore, the infection induces an immune imbalance in the hepatic tissue, leading to a severe destruction of its architecture due to intensive inflammatory infiltration in various sites of the body [36] . The pro-oxidant species tend to enhance the formation of reactive superoxide species in order Note that sensors S1 and S2 are composed of the same sensing material but have different baseline resistances and are not identical.
Abbreviation: NP, nanoparticle.
to destroy the pathogen, which in some cases introduces physiological disturbance in the cells that produce oxidative stress. Important metabolic processes, such as central carbon catabolism and protein synthesis, are therefore perturbed. As a result, alkene derivatives are thought to be generated from chain cleavage and recurrent oxidation products in the process of lipid peroxidation [37] . The long-chain hydrocarbon, 1-tridecene, in exhaled breath might originate as an intermediary species from the carbon catabolism in the process of acetyl coenzyme A decarboxylation, and its presence in CE pathogenesis might be related to enhanced production of inflammatory molecules during CE at different parts of the body, mainly in the liver [36, 38] .
(E)-13-Docosenoic acid belongs to the family of monounsaturated hydrocarbons with a polar carboxylic functional group, and is related to lipid peroxidation of polyunsaturated fatty acids (PUFAs) during and after monocyte adhesion to endothelial cells, enabling parasite survival in a pro-oxidant environment. Its presence in exhaled breath might be associated with long-chain ω-9 PUFA generation as a result of parasite-induced cytokine inflammatory activation and the oxidative damage of cell membrane lipids [39] .
Alveolar Echinococcosis
In the case of AE, the presence of hexadecane, heptadecane, and eicosane in exhaled breath might be a result of oxidative degradation of PUFAs inflicted by oxidative stress during chronic inflammation induced by Echinococcus infection [40, 41] . They are all straight-chain alkanes and their presence in exhaled breath can be associated with the peroxidation of various PUFAs such as linoleic and linolenic acids, which are cell membrane components [42] .
The long-chain alkanes 11-(pentan-3-yl)henicosane, tetratriacontane, 2-methyloctacosane, and hentriacontane can also be produced from lipid peroxidation of long-chain PUFAs. These VOCs are generated as a result of excess reactive oxygen species due to either overproduction of pro-oxidants or insufficient activity of antioxidants in the body. During the process of PUFA peroxidation, there is a scission of alkane fragments extending from the methyl end of the fatty acid to the double bond. Depending on the nature of the initial fatty acid, alkane molecules such as ethane and pentane are released by the oxidative damage of ω-3 PUFA and ω-6 PUFA, respectively [43, 44] . These molecules are partly metabolized in the liver by the microsomal oxidizing enzyme associated with cytochrome P-450 and/or released in the breath, indicating the extent of lipid peroxidation in the body during inflammation [32, 43] . Hence, the branched alkanes 11-(pentane-3-yl)henicosane and 2-methyloctacosane might undergo cytochrome P-450 metabolic processes once they are released as intermediate products of lipid peroxidation of long-chain PUFAs.
Chemical Sensors' Analysis
Based on the results obtained from the GC-MS analysis, an array of 8 chemoresistive gas sensors based on ultrapure MNP-ligand nanoassemblies (where M is Au, Pt, or Cu) were fabricated with the aim of achieving rapid and noninvasive detection of AE and CE in breath samples (Table 1) . Sensors S3 to S6 and S8 have a polar functional organic ligand in their tail with affinity to VOC01 and VOC02, while sensors S1, S2, and S7, with long-chain hydrocarbons ligands with nonpolar functional groups in their tail, exhibit relatively high affinity to VOCs with long nonpolar hydrocarbon chains, such as VOC03 to VOC09. In the present study, the sensors were operated in the dynamic mode by switching them successively for short periods of time between the ON (application of DC voltage) and OFF (no DC voltage) states without reaching steady state conditions, in order to assess their transient responses to the breath VOCs mixture, which contain more information than static measurements [45] .
Sensors' responses were measured as changes in the electrical current that flowed between the electrodes in the chemoresistive sensors upon exposure to the breath volatiles. Each sensor was characterized by rapid and reproducible response signals as well as good reversibility after finishing sample exposure (Supplementary Figure 2) . The sensors exhibited, on the one hand, completely different sensitivities when exposed to the same breath sample, while on the other hand they presented different overall response patterns for different health states (Supplementary Figure 3) , suggesting a broad cross-reactive sensor array that reacted differently with the breath VOCs mixture, and thus could a priori be employed to differentiate individuals' breath patterns [17, 19] .
The differences in the sensors' responses to different breath volatiles patterns were initially assessed for discrimination between the breath samples of the 24 CE and 28 CCE volunteers employing the indirect measurement method. Because of the reproducibility of the sensor responses during the different measurement cycles (as evidenced by Supplementary Figure 3) , only the first cycle was investigated in this analysis. Different combinations of features extracted from the sensors' responses during the first measurement cycle were tested to develop a classification model for the CE and CCE groups employing a DFA pattern recognition algorithm. The features calculated for all sensors were scaled to zero mean and unitary variance for each sample measured. Table 3 shows all sensor and feature combinations used in the present study. The DFA model built with 8 features extracted from 7 different sensors provided 100% accuracy, 100% sensitivity, and 100% specificity (values estimated through leave-one-out cross-validation, as explained in the "Methods" section) for CE classification, providing an excellent potential of the sensor system to diagnose CE from breath analysis.
Given these very promising results, the capability of the sensor array to diagnose CE on-site (directly in the hospital) F1  F2  F3  F1  F2  F3  F1  F2  F3  F1  F2  F3 S1
Abbreviations: AE, alveolar echinococcosis; CAE, control for alveolar echinococcosis; CCE, control for cystic echinococcosis; CE, cystic echinococcosis.
a Indirect measurements.
b Direct measurements. was also assessed by using the direct measurement method, whereby the sampled exhaled breath was directly exposed to the sensors without preconcentration and headspace extraction (Supplementary data). In this study, breath samples provided by 23 volunteers (8 CE patients and 15 CCE controls) were analyzed. The classification results revealed 82.6% accuracy, 75% sensitivity, and 86.7% specificity. The inferior performance of the direct measurement method can be attributed to the high relative humidity of the breath. In contrast, in the indirect measurements the VOCs hydrophobic storage material (Tenax TA) that was used to capture the breath VOCs does not retain water vapor (see "Methods" section). This result prevailed even though the sensors were operated at a lower voltage in the direct measurement mode (5 V instead of 8 V for the indirect method) Table 3 . Each volunteer is represented by 1 point in the box plot; the horizontal dashed lines represent the classification border between the groups. Right panels: receiver operating characteristic curves constructed with the CV1 of the DFA models. Areas under curve (AUC) values are given. Abbreviations: AE, alveolar echinococcosis; CAE, control for alveolar echinococcosis; CCE, control for cystic echinococcosis; CE, cystic echinococcosis.
to reduce the sensor response due to local condensation of water from the humidified breath samples. Water adds a competing conduction mechanism by ionic conduction in addition to the electron tunneling mechanism throughout the sensing film, and thus introduces additional noise in the data [46] .
Based on this result, the indirect method was employed for assessing the possibility of the sensor system to diagnose the AE form of the disease. In this study, breath samples provided by 22 volunteers (14 AE patients and 8 CAE controls) were analyzed. The discrimination accuracy between the breath prints of AE and CAE volunteers achieved by the DFA model built with 8 features extracted from 6 different sensors (Table 3) was 92.9%, while the sensitivity and specificity were 92.9% and 88.9%, respectively, demonstrating the high capability of the sensor system to accurately diagnose also the AE type of the echinococcosis disease.
Finally, because the analytical studies revealed different breath biomarkers for CE and AE, the capability of the sensor array to discriminate between CE and AE patients from exhaled breath analysis was evaluated. This analysis was performed with the breath samples provided by 38 patients (24 CE patients and 14 AE patients), and the DFA discriminative model built for this analysis with 8 features extracted from 5 different sensors achieved 92.1% accuracy, 91.7% sensitivity, and 92.7% specificity. Table 4 summarizes the classification results obtained in this study, and Figure 2 presents the corresponding graphical representation of the results. None of the classification models was cross-influenced by confounding factors such as gender and age (Supplementary data).
DISCUSSION
The collected results show remarkable accuracy for the diagnosis and detection of different types of HE (CE and AE) considering the simplicity of data collection and the straightforward DFA analysis of exhaled breath samples employing a chemoresistive sensor array. Such excellent classification capability of the sensor array might be attributable to the broad range of MNPligand nanoassemblies used as the sensing layer that provided different network structures [31] , in which each sensor reacted differently to the exhaled VOCs mixtures. This is supported by the fact that different sensors/features were suitable for the diagnosis and discrimination of the 2 types of the echinococcosis disease analyzed in this study, which is in accordance with the differences between CE and AE found by the analytical GC/Q-TOF analysis. Therefore, the combinations of individual sensor/ feature responses obtained with the highest sensitivity to the individual breath VOC patterns revealed the desired selectivity and provided distinguishable breath VOC patterns between CE and AE. One reason for differentiation of CE and AE is likely to be associated with the volatile biomarkers' chemical properties. The breath VOCs biomarkers identified for AE are longer-chain alkane hydrocarbons compared with those for CE, which can result in reduced ability for adsorption and diffusion into the nanoassembly network, and a concomitant reduced swelling of the nanoassembly films [47] .
On the other hand, the dynamic sensors' operation methodology proposed in this study allows for analysis of the kinetic reactions that occur between the sensing nanomaterial and the breath volatiles, which improved both the selectivity and sensitivity of the chemical sensors because each individual VOC from the breath produced a characteristic behavior for each type of sensor as a function of the voltage applied [45] .
The measurement of exhaled breath samples with a simple and easy-to-use chemical sensor array could represent a strategy to tackle the diagnosis and control of the most prevalent neglected diseases caused by helminths in remote areas that lack the necessary socioeconomic and medical facilities for combating these infectious diseases.
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